Multiplikator Forward P/S: Avinger (AVGR)
Avinger, Inc. generates revenue from the sale of visualization systems and consumables for minimally invasive vascular treatment. The forward P/S trajectory reflects market expectations, where 0.20 represents the current level of the metric. The company's success relies on the demand for Pantheris systems and sensor precision. Growth is supported by the robotization of laser catheter production and the implementation of AI-driven processing for diagnostic imaging.
Ringkesan rincian data analitis Avinger Inc (AVGR)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Avinger, Inc.|AVGR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Avinger, Inc.|AVGR - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Avinger Inc|AVGR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Avinger|Rasio cepet avinger.com
- rincian asil keuangan lan kelipatan valuasi:
AVGR - Penghasilan resik perusahaan|Bathi sing dikarepake Avinger, Inc.|AVGR - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Avinger, Inc|AVGR - Pangali PEG|Pangali EV/EBITDA Avinger Inc|AVGR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Avinger|AVGR - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan avinger.com|AVGR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Avinger, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:AVGR (Avinger)
The forward P/S reflects the market value of the business relative to expected annual sales volume, allowing for an assessment of the premium or discount to projected cash flows. By analyzing the forward P/S trend, an investor can see how market expectations are adjusting amid the slow adoption of Avinger, Inc. (AVGR) catheters in US clinics and liquidity shortage risks resulting from the company's operating losses.
Karo sapa Avinger, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|Beyond Air (XAIR) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan PFSA|Rasio rega marang prakiraan pendapatan SSKN|Multiplikator Forward P/S GCTK|Rasio kapitalisasi marang dodolan sing dikarepake NanoVibronix Inc.|Rasio rega marang prakiraan pendapatan Venus Concept Inc. VERO|NUWE: Kapitalisasi marang prakiraan pendapatan|Aethlon Medical, Inc. - Multiplikator Forward P/S|Prakiraan rega marang pendapatan Asensus Surgical, Inc. (ASXC)|BSGM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cutera Inc (CUTR)|Rasio rega marang prakiraan pendapatan Know Labs, Inc.|NARI: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
